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Abstract 
 
Marntell S. 2004. Sedation and dissociative anaesthesia in the horse. 
Physiological and clinical aspects. Doctoral dissertation. 
 
The overall aim of this investigation was to study the effects of different drug combinations 
for premedication and dissociative anaesthesia, to examine their suitability for field 
conditions and their ability to maintain cardiorespiratory function and provide sufficient 
analgesia for common, but challenging procedures such as castration. 
Haemodynamic parameters, pulmonary ventilation-perfusion relationships, and clinical 
effects were studied during sedation and dissociative anaesthesia. The effects of additional 
premedication and prolongation of dissociative anaesthesia and response to surgery were 
evaluated.  
The cardiorespiratory effects of romifidine and tiletamine-zolazepam anaesthesia did not 
differ significantly from those of prolonged romifidine and ketamine anaesthesia. 
Prolongation of anaesthesia with ketamine alone after romifidine/ketamine resulted in a 
poor quality of anaesthesia.  
There was a decrease in arterial oxygenation during sedation with α2-agonists, which was 
mainly attributed to a reduced cardiac output and increased ventilation-perfusion mismatch. 
During dissociative anaesthesia the cardiac output did normalise, but arterial oxygenation 
was further impaired as a result of increased intrapulmonary shunt and increased 
ventilation-perfusion mismatch. Administration of acepromazine before sedation with 
romifidine and butorphanol resulted in better maintenance of circulation and partly 
prevented the anaesthesia-induced ventilation-perfusion disturbances and fall in arterial 
oxygen tension. Although the arterial oxygenation was further impaired during anaesthesia 
and recumbency compared to that during sedation, the oxygen delivery did not decrease 
further. On the contrary, the arterial-mixed venous oxygen content difference and mixed 
venous oxygen tension remained closer to standing unsedated values during anaesthesia 
than in the sedated horse. 
Breathing high oxygen concentrations (>95% oxygen) during dissociative anaesthesia 
improved arterial oxygenation compared to air breathing (21% oxygen), but concomitantly 
increased intrapulmonary shunt and introduced hypoventilation. The intrapulmonary shunt 
created during anaesthesia with high oxygen concentrations persisted when the horses 
returned to air breathing, possibly indicating that resorption atelectasis produced during 
high oxygen breathing subsequently persisted during anaesthesia and recumbency. 
Tiletamine-zolazepam anaesthesia, after premedication with acepromazine, romifidine 
and butorphanol, produced anaesthesia and analgesia sufficient for castration of colts under 
field conditions. When the same regimen was used in the animal hospital there was a need 
for supplementary anaesthesia in some cases to complete surgery. The induction, 
anaesthesia and recovery were calm and without excitation in all colts both under hospital 
and field conditions. Cardiorespiratory changes during air breathing were within acceptable 
limits in these clinically healthy horses. 
 
Key words: horses, field anaesthesia, additional premedication, prolonging dissociative 
anaesthesia, respiration, circulation, pulmonary gas exchange, intrapulmonary shunt, α2-
agonists, butorphanol, acepromazine, ketamine, diazepam, tiletamine, zolazepam.  
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Abbreviations 
 
ASAT    Aspartate  aminotransferase 
CaO2      Arterial  oxygen  content 
C(a-v)O2      Arterial-mixed venous oxygen content difference 
C(a-jv)O2     Arterial-jugular venous oxygen content difference 
C K        C r e a t i n e   k i n a s e    
FIO2     Inspired  fraction  of  oxygen 
Hb       Haemoglobin  concentrations 
H R        H e a r t   r a t e  
HPV      Hypoxic  pulmonary  vasoconstriction 
kPa       kilopascal 
log SDQ       Logarithmic standard deviation of the perfusion distribution 
log SDV       Logarithmic standard deviation of the alveolar ventilation 
PAO2      Alveolar  oxygen  tension 
P(A-a)O2      Alveolar-arterial oxygen tension difference 
PaCO2    Arterial  carbon  dioxide  tension 
PaO2      Arterial  oxygen  tension 
PAP     Pulmonary  arterial  pressure 
PjvO2      Jugular  venous  oxygen  tension 
PvO2      Mixed  venous  oxygen  tension 
Qmean     Mean  distribution  of  perfusion 
Qt      Cardiac  output 
R R        R e s p i r a t o r y   r a t e  
SAP     Systemic  arterial  pressure 
SV       Stroke  volume 
TSR     Total  systemic  vascular  resistance 
VD/VT       Dead space to tidal volume ratio 
VE       Expired  minute  ventilation 
Vmean     Mean  distribution  of  ventilation 
VT       Tidal  volume 
VA/Q      Ventilation-perfusion  ratio 
Qs/Qt      Intrapulmonary  shunt 
 
Abbreviations for sedative and anaesthetic protocols: 
De: Detomidine 
DeB: Detomidine + butorphanol 
RK: Romifidine + ketamine 
RBK: Romifidine + butorphanol + ketamine 
RDK: Romifidine + diazepam+ ketamine 
ARK: Acepromazine + romifidine + ketamine 
RK+K: Romifidine + ketamine, repeated dose of ketamine 
RK+RK: Romifidine + ketamine, repeated doses of both romifidine and ketamine 
RZ (RT/Z): Romifidine + Zoletil
®(tiletamine/zolazepam) 
RBZ: Romifidine + butorphanol + Zoletil
®(tiletamine/zolazepam) 
ARBZ: Acepromazine+ romifidine+ butorphanol + Zoletil
®(tiletamine/zolazepam) 
ARBZ-O2: Drug-combination same as ARBZ, but during anaesthesia the horses 
breathed more than 95% oxygen the first 15 minutes, thereafter air (21% oxygen).   5
Introduction 
 
 
 “The success of a veterinarian as a surgeon depends in no small degree on his  
knowledge of anaesthetics and his skills in their administration” J.G. Wright 1941.  
 
For veterinarians working in general practice the need for knowledge of 
anaesthetics and skills in their administration is as great today as it was in 1941. 
This is especially true for veterinarians treating horses in remote areas, with many 
hours of driving to reach a large-animal clinic or hospital.  
 
The horse is a large animal, entailing a risk for accidents to surrounding persons. 
The temperament of this animal often precludes the use of local analgesia without 
heavy sedation (Hall & Clarke 1991). Sedation with the α2-adrenoceptor agonists 
(α2-agonists) detomidine, romifidine and xylazine has been found useful in equine 
practice. The principal physiological effects of the different α2-agonists are 
similar, in that they produce a reduction in heart rate, a decrease in cardiac output 
and initial hypertension followed by prolonged hypotension (England & Clarke 
1996).  The sedated horse must be handled with caution, as the animal may be 
aroused by stimulation and can respond with very well aimed kicks (Clarke & 
Taylor 1986; Hall, Clarke & Trim 2001). Thirty-one veterinary accidents 
involving horses were reported to the Swedish Work Environment Authority 
during 1997-2001, compared to 14 involving dogs (Bengtsson 2003). Sometimes 
the risk of injuries will be reduced and the ability to perform surgery improved if 
the horse is anaesthetised. However, anaesthetisation of the horse is still a 
challenge for the veterinarian, and the risk of mortal complications is higher for 
the horse than for dogs and cats (Jones 2001). The perioperative mortality rate 
among apparently healthy horses undergoing general anaesthesia is around 1% 
(Johnston et al. 2002). One-third of the deaths were caused by cardiac arrest, one-
third originated from fractures and myopathies, and the remaining third resulted 
from a range of causes.  
  
In early years inhalation anaesthesia in the horse was performed with a simple 
mask, where a sponge containing chloroform was applied in direct contact with 
the nostrils. This method was previously used in field practice for induction of 
anaesthesia or for administration in the restrained horse in the recumbent position. 
One danger associated with chloroform was cardiac failure during induction and 
another was delayed poisoning due to a toxic effect on the liver and kidneys 
(Wright 1947).  
Ether, which has no delayed toxic action on the liver, could not usually be 
delivered in concentrations sufficient to produce surgical anaesthesia when used 
on an open mask in the horse. To overcome this problem, Henkels (1938) 
developed an apparatus for administration of ether to horses. Drawbacks with 
ether are its high flammability and the fact that mixtures of its vapour with oxygen 
or air in certain proportions are explosive. The real incentive for further 
development of inhalation anaesthesia for horses came from the discovery of 
halothane in 1956 (Hall & Clarke 1991, Jones 1993). Today inhalation anaesthesia   6
with halothane and isoflurane is widely used in the horse. However, the use of 
anaesthetic gases is better regulated today in consideration of occupational health 
aspects (AFS 2001:7), but bringing anaesthetic machines and all necessary 
equipment to the field is not possible for veterinarians working in general practice. 
  
Castrations have long been a common but challenging surgical procedure and in 
the textbook Veterinary Anaesthesia of 1947 Wright describes anaesthesia for 
castration of the horse, both in the standing position and in the cast (recumbent) 
position. The cast position was preferred for large mature subjects and the 
standing position for one- to two-year-old colts. Hudson (1919) described standing 
castration under local anaesthesia and Wright modified the technique and 
commented that in this somewhat hampered situation (applying local anaesthetics 
with only a twitch applied to the upper lip), the operator must be prepared for 
animal movements on insertion of the needle. If it becomes necessary to make a 
series of stabs with the needle, the animal may become vigorous and the method 
will fail (Wright 1947).  
  
In field conditions intravenous anaesthesia is usually the method of choice, as it 
can be performed without the facilities at hand in animal hospitals, such as 
induction stalls, transport systems, padded recovery rooms and skilled assisting 
personnel. In the absence of these facilities, anaesthetic protocols intended for use 
in field practice need to achieve calm induction, anaesthesia and recovery without 
excitation and without danger for the horse or helping personnel.  
During anaesthesia, the circulation and respiration should be well maintained, 
with adequate oxygen delivery to the tissues and with anaesthesia and analgesia 
sufficient for surgery. Intravenous anaesthesia has been advocated as more 
favourable than inhalation on the basis of cardiorespiratory data (Taylor et al. 
1992, 1998; Luna et al. 1996). Further, results of Johnston et al. (2000, 2002) 
have indicated that the mortality rate is lower with total intravenous anaesthesia 
than with inhalation anaesthesia. The two intravenous anaesthetics ketamine and 
tiletamine are both congeners to phencyclidine and are referred to as dissociative 
anaesthetics. Ketamine's low ability to cause cardiorespiratory depression is 
unequalled by other general anaesthetics (Lanning & Harmel 1975).  Most of the 
pharmacological actions of tiletamine are similar to those of ketamine, but the 
duration is longer (Branson 2001).  
 
Combinations of α2-agonists and dissociative anaesthetics are commonly used for 
induction and maintenance of short-term equine anaesthesia; however, impaired 
arterial oxygenation is often reported (Muir et al. 1977, 1999, 2000; Ellis et al. 
1977; Hall & Taylor 1981; Clarke et al. 1986; Hubbell et al. 1989, 2000; 
Matthews et al. 1991ab; Wan et al. 1992; Taylor et al. 1992, 1998; Kerr et al. 
1996). Even when horses are ventilated with a high fraction of oxygen during 
anaesthesia, it is sometimes difficult to keep them well oxygenated (Hubbell et al. 
1986). Studies of equine pulmonary dysfunctions occurring with use of different 
anaesthetic protocols and body positions have mainly been conducted during 
inhalation with 100% oxygen. Studies of the ventilation-perfusion relationship 
have shown that a large right to left vascular shunt develops during inhalation 
anaesthesia in horses (Nyman & Hedenstierna 1989; Nyman et al. 1990). In human studies, inhalation of 100% oxygen during anaesthesia has been found to 
promote atelectasis and intrapulmonary shunt, in contrast to inhalation of 30% 
oxygen in nitrogen (Rothen et al. 1995a). No equine study has addressed the effect 
of breathing high oxygen concentrations on the pulmonary ventilation-perfusion 
ratio during dissociative anaesthesia.  
Premedication with acepromazine alone or in combination with α2-agonists has 
been reported to reduce the risk of anaesthetic complications (Johnston et al. 1995, 
2000). However, the effects on the pulmonary ventilation-perfusion ratio produced 
by α2-agonists alone or in combination with acepromazine during sedation and 
during subsequent anaesthesia in the horse have not been studied. 
Although intravenous anaesthesia has been advocated on cardiorespiratory 
grounds, the anaesthesia and analgesia have sometimes been reported to be 
inadequate for surgery. In a study comparing four anaesthetic protocols for 
surgical removal of abdominal testis, it was found that 8 out of 32 horses had to be 
changed from intravenous to inhalation anaesthesia because of inadequate 
analgesia (Muir et al. 2000). In field conditions, xylazine/ketamine anaesthesia 
resulted in a need for supplemental thiopentone in 7 of 10 ponies, and during 
detomidine/ketamine anaesthesia 5 of 10 ponies needed thiopentone (Clarke et al. 
1986). 
  There is a need for a reliable method of anaesthesia in equine field practice. The 
anaesthesia produced by α2-agonists and ketamine is of short duration and 
sometimes inadequate for surgery. In our experience the short duration has also 
made them unsuitable for castration carried out by students. The hypothesis 
proposed was that dissociative anaesthesia can be improved and prolonged 
without impairment of the quality of induction or recovery and with maintenance 
of acceptable cardiorespiratory function under field conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 The head holder evaluating the pulse quality during the first minute  
after induction under field conditions. Note the extended head and neck of the  
horse to help maintain a patent airway. 
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Aims of the study 
 
 
The overall aim of this investigation was to study the effects of different drug 
combinations for premedication and dissociative anaesthesia, to examine their 
suitability for field conditions and their ability to maintain cardiorespiratory 
function and provide sufficient analgesia for common, but challenging procedures 
such as castration. 
 
The specific aims were: 
 
1.  To determine whether premedication with acepromazine, butorphanol or 
diazepam, in addition to romifidine, before induction of anaesthesia with 
ketamine, could improve the quality of anaesthesia without having 
adverse circulatory and respiratory effects. (Study I) 
 
2.  To compare the cardiorespiratory and clinical effects of 
romifidine/tiletamine-zolazepam anaesthesia with those of prolonged 
romifidine/ketamine anaesthesia. (Study II) 
 
3.  To evaluate the ventilation-perfusion relationships, gas exchange and 
cardiovascular response during sedation with an α2-agonist (detomidine 
or romifidine) in combination with butorphanol or acepromazine and 
butorphanol, and during subsequent dissociative anaesthesia. (Studies 
III-IV) 
 
4.  To study the effect of a high fraction of oxygen on pulmonary function 
and gas exchange during dissociative anaesthesia in horses. (Study V) 
 
5.  To evaluate the cardiorespiratory function with use of three dissociative 
anaesthetic protocols and the suitability of these protocols for castration 
of colts under hospital conditions; and further, to test the most suitable of 
these anaesthetic protocols for castration under field conditions. (Study 
VI) 
   9
Materials and methods 
 
Animals 
This investigation was carried out on 76 clinically healthy horses. In one study 
(III) the procedures involved sedation in 7 horses. In studies I, II, IV, V and VI 
both sedation and subsequent anaesthesia were carried out, in total 117 times. The 
anaesthesia was performed with ketamine on 36 occasions and with tiletamine-
zolazepam on 81 occasions. Surgical castration was performed on 57 colts (study 
VI). 
 
Studies I and II were conducted on six Standardbred trotters, three mares and 
three geldings, weighing 405-540 kg (mean 450 kg) and of ages 5-14 years (mean 
9 years). Study III comprised seven Standardbred trotters, 2 mares and 5 geldings, 
weighing 380-520 kg (mean 457 kg) and of ages 3-7 years (mean 5 years). Studies 
IV and V were performed on six Standardbred trotters, four geldings and two 
mares, aged between 3 and 12 years (mean 6 years) and weighing 423-520 kg 
(mean 470 kg). In study VI, a clinical investigation, there were 57 horses. This 
study was divided into two parts, one performed under hospital conditions and one 
under field conditions. Under hospital conditions 26 colts were castrated in the 
animal hospital at the Swedish University of Agricultural Sciences. These colts 
had a mean weight of 417 kg (165-623 kg) and a mean age of 2.5 years (1.5-5 
years). Seven different breeds were represented: 13 Swedish warmbloods, 6 
Standardbred trotters, 5 ponies (Dartmoor, Shetland, Welsh), one Coldblood 
trotter and one Lippizaner. Under field conditions, 31 colts with an estimated 
mean weight of 450 kg (390-600 kg) and a mean age of 1.5 years (1.5-2.5 years) 
were included. Breeds represented were 28 Swedish Warmbloods, one Arab 
crossbreed, one New Forest pony and one Coldblood draft horse. 
 
Study design  
Studies I, II, IV and V were randomised crossover studies and Studies III and VI 
were treatment response studies. In study VI the part carried out under hospital 
conditions was randomised. In studies I, II, IV, V and VI, measurements and 
sampling were performed in the standing unsedated horse (Baseline), in the 
sedated horse (Sedation), during anaesthesia, and after anaesthesia (Post). 
Sedation measurements were made in the standing horse 2-8 minutes after the 
sedative drugs were administered. Measurements during anaesthesia were made 5, 
15, 25 and 35 minutes after the horse had entered lateral recumbency. Post 
measurements were performed approximately 5 minutes after the horse had 
retuned to a standing position. In study III, measurements and sampling were 
performed 15 minutes after sedation with detomidine and 15 minutes after 
subsequent butorphanol administration. 
 
Study procedure 
In all horses food was withheld for 10-12 hours prior to anaesthesia, but access 
was given to straw bedding and water. In 25 of the horses castrated under field   10
conditions, access was allowed to grass pasture. Before induction of anaesthesia, 
pads of cotton wool were placed in the horse´s ears to reduce external stimuli. 
During induction one person held the halter and in studies IV-VI one person held 
the tail or a tail rope for balance, to prevent the horse from falling forward. After 
induction, the horse was left undisturbed for one minute, but the head and neck 
were extended to help maintain a patent airway (Fig. 1). The eyes were protected 
with a piece of cloth. The horses were not intubated in studies I, II and VI, but in 
studies IV and V intubation was necessary to measure the ventilation and sample 
expired gases. The horses breathed spontaneously throughout all studies. The 
horses were placed in lateral recumbency in all studies and in dorso-lateral 
recumbency during surgical procedures in study VI, with the chest mainly in the 
lateral and the hindquarters in the dorsal position (Figs. 3 and 4). After completion 
of surgery the horse was returned to lateral recumbency. In study VI each hind leg 
was held with a rope or supported with straw bales, a safety precaution that also 
kept the horse in balance and gave the surgeon access to the surgical area. The ear 
pads were removed approximately 45 minutes after induction. The horses were 
never forced to stand in any study, nor were they helped to stand in studies I and 
II or in the part performed at the animal hospital in study VI. Under field 
conditions in study VI and in studies IV and V, one person held the halter and one 
person held the tail when the horse attempted to stand.  
 
Catheterisation 
In studies I-V catheterisations were performed with the horse standing and 
unsedated, after local analgesia with lidocaine (Xylocain
® 2%, Astra, Södertälje, 
Sweden). A catheter was introduced percutaneously into the facial artery (18G, 
Hydrocath TM arterial catheter, Omeda, UK) and an infusion catheter (14G, 
Intranule, Vygone, France) was placed in the left jugular vein. In studies III-V a 
second infusion catheter was placed in the left jugular vein. A thermodilution 
catheter (7F, Swan-Ganz, Edwards lab., Santa Ana, CA, USA) was inserted with 
an introducer kit (8F, Arrow Int. Inc., Reading, PA, USA) through the right 
jugular vein into the pulmonary artery. A pigtail catheter (Cook Europe A/S, 
Söborg, Denmark) was introduced by the same technique into the right jugular 
vein, advanced to the right ventricle and then retracted into the right atrium. The 
venous catheters were positioned under pressure-tracing guidance. Once correctly 
placed, the catheters were locked in position with Luer-lock adapters. In study VI 
one infusion catheter (14G, Intranule, Vygone, France) was placed in the jugular 
vein before induction. Under hospital conditions a facial artery catheter was 
placed immediately after induction of anaesthesia.  
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Anaesthetic protocols 
The anaesthetic protocols used within the frame of the study were randomised and 
at least 7 days’ rest was allowed between them. All drugs were administered 
intravenously (i.v.) except for acepromazine (Plegicil
® vet, 10 mg/ml, Pherrovet 
AB or Pharmacia & Upjohn Animal Health, Sweden), which was always given 
intramuscularly (i.m.). The horses breathed air (FIO2=0.21) spontaneously during 
anaesthesia, except in protocol ARBZ-O2, where they spontaneously breathed a 
high fraction of oxygen (FIO2>0.95) in the first 15 minutes of anaesthesia and 
thereafter air. The different sedative and anaesthetic protocols were as follows: 
 
DeB: Sedation was induced with detomidine 0.02 mg/kg (Domosedan
® vet. 10 
mg/ml, Orion Pharma Animal Health, Sollentuna, Sweden). After 20 minutes 
butorphanol 0.025 mg/kg (Torbugesic
® 10 mg/ml, Fort Dodge, Iowa, USA) was 
administered. 
 
RK: Sedation was induced with romifidine 0.1 mg/kg (Sedivet
® vet., 10 mg/ml, 
Boehringer Ingelheim Vetmedica, Malmö, Sweden); 7 minutes later anaesthesia 
was induced with ketamine 2.2 mg/kg (Ketaminol
® 100 mg/ml, Veterinaria AG, 
Zürich, Switzerland). 
 
RBK: Romifidine 0.1 mg/kg; followed 2 minutes later by butorphanol 0.025 
mg/kg. After a further 5 minute anaesthesia was induced with ketamine 2.2 mg/kg. 
 
RDK: Romifidine 0.1 mg/kg; 7 minutes later anaesthesia was induced with 
ketamine 2.2 mg/kg. Diazepam 0.05 mg/kg (Apozepam
® 5mg/ml Apothekernes 
laboratorium, Oslo, Norway) was administered immediately before the ketamine. 
 
ARK: Acepromazine 0.025 mg/kg was given 23 minutes before romifidine 0.1 
mg/kg, and 7 minutes after romifidine administration anaesthesia was induced 
with ketamine 2.2 mg/kg. 
 
RK+K: Romifidine 0.1 mg/kg; 7 minutes later anaesthesia was induced with 
ketamine 2.2 mg/kg. A repeated dose of ketamine 1.1 mg/kg was given 18-20 
minutes after the start of the first ketamine injection used for induction. 
 
RK+RK: Romifidine 0.1 mg/kg; 7 minutes later anaesthesia was induced with 
ketamine 2.2 mg/kg. Repeated doses of both romifidine 0.04 mg/kg and ketamine 
1.1 mg/kg were given 18-20 minutes after the start of the first ketamine injection 
used for induction. 
 
RZ: Romifidine 0.1 mg/kg; 7 minutes later anaesthesia was induced with 1.4 
mg/kg Zoletil
® (tiletamine 0.7 mg/kg in combination with zolazepam 0.7 mg/kg 
[Zoletil 100
® 100 mg/ml, Virbac, Carros, France]).  
 
RBZ: Romifidine 0.1 mg/kg; followed one minute later by butorphanol 0.025 
mg/kg. Twelve minutes after romifidine, anaesthesia was induced with 1.4 mg/kg 
Zoletil
®. ARBZ and ARBZ-O2: Acepromazine 0.035 mg/kg was given 20 minutes before 
romifidine 0.1 mg/kg, followed one minute later by butorphanol 0.025 mg/kg. 
Twelve minutes after romifidine, anaesthesia was induced with 1.4 mg/kg Zoletil
®. 
 
Clinical investigation: 
The RZ-hospital group: Romifidine 0.11 mg/kg (range 0.1-0.14 mg/kg); Seven 
minutes after romifidine, anaesthesia was induced with 1.4 mg/kg Zoletil
®  
 
The ARZ-hospital group: Acepromazine 0.033 mg/kg (range 0.025-0.05 mg/kg); 
30-45 minutes later romifidine 0.11 mg/kg (range 0.1-0.15 mg/kg). Seven minutes 
after romifidine administration, anaesthesia was induced with 1.4 mg/kg Zoletil
®. 
 
The ARBZ-hospital group: Acepromazine 0.045 mg/kg (range 0.045-0.05 mg/kg); 
30-45 minutes before romifidine 0.1 mg/kg, followed one minute later by 
butorphanol 0.025 mg/kg. Seven minutes after romifidine administration, 
anaesthesia was induced with 1.4 mg/kg Zoletil
®. 
 
The ARBZ-field group: Acepromazine 0.035 mg/kg 20-45 minutes before 
romifidine 0.1 mg/kg, followed one minute later by butorphanol 0.025 mg/kg. 
Five to 7 minutes after romifidine administration, anaesthesia was induced with 
1.4 mg/kg Zoletil
®. 
 
 
Sedation                      Anaesthesia 
                                 Induction          Prolongation 
A                                    R   B         D K or Z            RK or K  
 
 
  Time (min)
Figure 2  Schematic drawing of time between drug administrations in the different 
anaesthetic protocols. 
 
 
 
Table 1 Summary of sedative and anaesthetic protocols used and number (n) of horses 
investigated with the respective protocol. 
Protocol Sedation Anaesthesia  Study 
DeB  (n=7)    De           B No anaesthetics given  III 
RK (n=6)    R  K    I 
RBK  (n=6)    R     B  K    I 
ARK (n=6)  A  R  K    I 
RDK (n=6)    R K    I 
RK + RK  (n=6)    R  K  RK  II 
RK + K  (n=6)    R  K  K  II 
RZ (n=12)    R  Z    II, VI 
ARZ (n=11)  A  R  Z    VI 
RBZ  (n=6)    R     B  Z    IV 
ARBZ  (n=46)  A  R     B  Z    VI, V, IV 
ARBZ-O2  (n=6)  A  R     B  Z       V 
De=detomidine, B=butorphanol, A=acepromazine, R=romifidine, D=diazepam, 
K=ketamine and Z=Zoletil
® (tiletamine and zolazepam). 
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Time measurements and quality assessments 
The time from injection of ketamine or Zoletil
® to lateral recumbency was 
recorded in studies I, II and IV-VI, and the time to muscle relaxation in studies I 
and II. The duration of surgery was recorded in study VI and the lengths of time 
in lateral and sternal recumbency were recorded in studies I, II and IV-VI. The 
quality of induction, anaesthesia and recovery was assessed subjectively in studies 
I and VI, using a 0 to 3 scale, where 0=poor, 1=fair, 2=good and 3=very good.  
 
Response to noxious stimuli and surgery 
In studies I and II the response to noxious stimuli was tested by the pin-prick 
method on the coronary band of the front and hind leg, the shoulder and the 
gaskin. If purposeful skeletal muscle movement was observed at any of the 4 test 
sites, this was interpreted as a response. In study VI the surgeon, blinded with 
respect to the anaesthetic protocol, decided whether supplementary anaesthesia 
was needed to complete the surgical procedure performed under hospital 
conditions. 
 
 
Measurements of haemodynamic parameters 
Cardiac output (Qt) was determined by the thermodilution technique (Muir et al. 
1976; Nyman & Hedenstierna 1988). A bolus of 20 ml ice-cold 0.9% saline was 
rapidly injected into the right atrium through the pigtail catheter and the 
temperature was measured through a Swan-Ganz catheter. Cardiac output was 
then calculated by a cardiac output computer (Cardiac Output Computer Model 
9520 A, Edwards Lab., Santa Ana, CA, USA). Systemic arterial and pulmonary 
arterial blood pressure (SAP and PAP) were measured by connecting the arterial 
catheters via fluid-filled lines to calibrated pressure transducers (Baxter Medical 
AB, Eskilstuna, Sweden) positioned at the level of the scapulo-humeral joint when 
the horse was standing and at the level of the sternal manubrium in lateral 
recumbency. Blood pressure and electrocardiogram (ECG) were recorded on an 
ink-jet recorder (Sirecust 730, Siemens-Elema, Solna, Sweden). Heart rate (HR) 
was measured by auscultation or palpation or was recorded from the ECG. 
 
Measurements of pulmonary function and gas exchange 
Respiratory rate (RR) was measured by observing the costo-abdominal movements 
in all studies. Expired minute ventilation (VE) was measured with a Tissot 
spirometer (Collins Inc., Braintree, MA, USA) in the standing horse in studies III, 
IV and V. Respiratory rate and tidal volume (VT) were measured at the 
mouthpiece of the endotracheal tube during anaesthesia in studies IV and V, using 
side stream spirometry (Capnomac Ultima, Datex, Finland) (Moens et al. 2003).  
Arterial (a), mixed venous (v) or jugular venous (jv) blood samples for 
measurements of oxygen and carbon dioxide tensions (PaO2, PvO2, PjvO2, PaCO2, 
PvCO2) and oxygen saturation of haemoglobin (SaO2, SvO2) were drawn 
simultaneously and anaerobically into heparinised syringes and stored on ice until 
analysed by means of conventional electrode techniques (ABL 5 or ABL 300,   14
Radiometer, Copenhagen, Denmark). Haemoglobin concentration (Hb) was 
determined spectrophotometrically (Ultrolab system, 2074 Calculating 
Absorptiometer LKB Clinicon, Bromma, Sweden or Celtin 3500, Abbott 
Scandinavia AB, Solna, Sweden). Blood samples for Hb measurements were taken 
at baseline and during sedation in studies III, IV and V, and during anaesthesia in 
studies IV, V and VI. 
  Samples of blood and expired gas for measurements of gas concentration by the 
multiple inert gas elimination technique were taken at baseline and during sedation 
in studies III, IV and V and also at 15 and 25 minutes of anaesthesia in studies IV 
and V. The distribution of ventilation and perfusion (VA/Q) was estimated by the 
multiple inert gas elimination technique (Wagner et al. 1974a; Hedenstierna et al. 
1987). Six gases (sulphur hexafluoride, ethane, cyclopropane, enflurane, diethyl 
ether and acetone), inert in the sense of being chemically inactive in blood, were 
dissolved in isotonic Ringer acetate solution (Pharmacia, Stockholm, Sweden) and 
infused into the jugular vein at 30 ml/min. Arterial and mixed venous blood 
samples were drawn and simultaneously mixed expired gas was collected from a 
heated mixing box connected to a nose mask (standing measurements) or 
connected to the tracheal tube (anaesthesia measurements). Gas concentrations in 
the blood samples and expirate were measured by the method of Wagner et al. 
(1974a), using a gas chromatograph (Hewlett Packard 5890 series II, Atlanta, GA, 
USA). The arterial/mixed venous and mixed expired/mixed venous concentration 
ratios of each gas (retention and excretion, respectively) depend on its blood-gas 
partition coefficient and the VA/Q of the lung. The retention and excretion were 
calculated for each gas, and the solubility of each gas in blood was measured in 
each horse by a two-step procedure (Wagner et al. 1974b). The solubilities were 
similar to those reported from a previous study (Hedenstierna et al. 1987). These 
data were then used for deriving the distribution of ventilation and blood flow in a 
50-compartment lung model, with each compartment having a specific VA/Q ratio 
ranging from zero to infinity. Ventilation and blood flow in healthy subjects have 
a log normal distribution against VA/Q ratios. This means that the distributions of 
ventilation and of blood flow against VA/Q ratios intersect each other at a VA/Q of 
1, that perfusion exceeds ventilation in regions with VA/Q ratios below 1, and that 
ventilation exceeds perfusion in compartments with VA/Q ratios above 1. Of the 
information obtained concerning the VA/Q distribution, data are presented for the 
mean and standard deviation of the blood flow log distribution (Qmean and log 
SDQ, respectively), shunt (perfusion of lung regions with VA/Q <0.005), and the 
mean and standard deviation of the ventilation log distribution (Vmean and log 
SDV, respectively). All subdivisions of blood flow and ventilation are expressed 
in per cent of cardiac output and expired minute ventilation, respectively. The 
difference between measured PaO2 and PaO2 predicted on the basis of the amount 
of ventilation-perfusion mismatching and shunt (predicted-measured PaO2) was 
determined. This difference reflects diffusion limitation.  
 
Measurements of lactate and muscle enzymes 
Venous blood samples were taken from four horses 24 hours after anaesthesia 
with protocols ARK, RBK, RDK, RK+K, RK+RK and RZ for measurements of 
aspartate aminotransferase (ASAT) and creatine kinase (CK), which were made with a kinetic UV test (Konelab 30, Kone Instruments Espoo, Finland). Venous 
blood samples were collected at baseline, during sedation, at the beginning of 
anaesthesia, at the end of anaesthesia and after standing from two horses with 
protocols RZ, ARK and RK+K and one horse with protocols RBK, RDK and 
RK+RK, for measurements of plasma lactate concentrations with an enzymatic 
lactate analyser (Anolox GM-7, Anolox Instruments Ltd, London, UK). 
 
Calculations and statistics 
From the measured values obtained, the following calculations were made, using 
standard equations:  
Stroke volume (SV) = Qt/HR 
Total systemic vascular resistance (TSR) = mean SAP/Qt. 
Arterial, mixed venous or jugular venous oxygen content (CyO2) = Hb (g/100 ml) 
x 1.39 x SyO2 + PyO2 x 0.003 (y = a, v or jv). 
Arterial-mixed venous or arterial-jugular venous oxygen content difference  
(C(a-z)O2)  = CaO2 – CzO2 (z = v or jv). 
Expired minute ventilation (VE) = VT x RR. 
Alveolar oxygen tension (PAO2) = inspired oxygen tension (PIO2) – (PaCO2/R), 
where R (a constant) = 0.8. 
Alveolar-arterial oxygen tension differences (P(A-a)O2) = PAO2 – PaO2. 
Oxygen delivery = CaO2 x Qt. 
Oxygen uptake = Qt x C(a-v)O2. 
 
For statistical analysis the Statistica software package (Statsoft Inc., Tulsa, OK, 
USA) was used. The physiological data were analysed by one-way or two-way 
analysis of variance for repeated measures (ANOVA). When the ANOVA 
indicated a significant difference or interaction, Tukey’s HSD post hoc test or 
planned comparison was applied to describe the patterns of differences. Time 
measurements were compared by the Wilcoxon rank-sum test. A p value of < 0.05 
was considered significant in all tests. Results are given as mean values ± SE in 
studies I-II and as mean values ± SD in studies III-VI. 
 
 
Figures 4 & 5 Castration performed with students 
 Under field conditions. 
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Results and discussion 
 
Additional premedication 
Controlled and smooth induction of anaesthesia is important, particularly under 
field conditions (Matthews & Hartsfield 1993). The use of α2-agonists and 
ketamine results in good induction, with retention of muscle tonus during the 
induction procedure. The horse first sits down on its hind legs and then turns to the 
side when lying down. These inductions are easily controlled with one person 
holding the horse’s halter. A disadvantage previously noted with romifidine and 
ketamine anaesthesia was that in some horses rigidity and muscle twitching 
persisted during anaesthesia (Marntell et al. 1994). Inclusion of acepromazine in 
the premedication in study I resulted in inductions of good quality, with preserved 
muscular tone and a significantly shorter induction time, 74±6 seconds, compared 
to 118±10 seconds for romifidine and ketamine alone (Table 2). Addition of a 
benzodiazepines, diazepam in study I and zolazepam in study II, provided good 
muscle relaxation during induction and anaesthesia. One disadvantage observed, 
however, was that in some horses muscle relaxation occurred before the induction 
of anaesthesia, sometimes resulting in an abrupt fall towards the person holding 
the head. This can be prevented by the use of a tail or tail rope holder to balance 
the fall.  
 In  studies  I and II, the response to noxious stimuli appeared 5-10 minutes before 
the horse rolled from lateral to sternal recumbency. The recovery from short-term 
anaesthesia is a critical period; if the horse attempts to stand before it is capable of 
supporting itself adequately, the resulting struggle and ataxia can lead to injury of 
the horse and/or bystanders (Brouwer 1985). It is preferable that the horse rests 
undisturbed in sternal recumbency before standing. Interestingly and somewhat 
unexpectedly, additional premedication with butorphanol resulted in a 
significantly longer time spent in sternal recumbency, 19±5 minutes compared to 
8±2 minutes with romifidine and ketamine alone. One mare, which always rose 
immediately from the lateral to the standing position without resting in the sternal 
position with all other protocols both in studies I and II, rested for 12 minutes in 
the sternal position after receiving butorphanol. The horses reached a standing 
position at the first attempt after all protocols in both studies I and II. When the 
protocol had included diazepam or zolazepam, the recovery was slightly more 
ataxic, especially in the individuals spending no or only a short time in sternal 
recumbency.  
In study I, administration of the α2-agonist romifidine resulted in a significantly 
decreased heart rate accompanied by second-degree atrioventricular (AV) block. 
Administration of ketamine after premedication with romifidine returned the heart 
rate to baseline values, but the arterial blood pressure was significantly increased. 
The arterial oxygen tension decreased significantly during sedation and 
anaesthesia. The cardiorespiratory changes are in conformity with previous reports 
after sedation with α2-agonists and anaesthesia with ketamine (Muir et al. 1977; 
Hall & Taylor 1981; Clarke et al. 1986; England et al. 1992; Kerr et al. 1996). 
Additional premedication with butorphanol or diazepam did not alter the influence 
of romifidine or ketamine on the cardiorespiratory parameters. Inclusion of   17
acepromazine in the premedication maintained the haemodynamic parameters 
closer to the standing unsedated values. 
 
Table 2  The mean length of time, ± SE, from ketamine administration to lateral 
recumbency (induction), to muscle relaxation, to noxious stimulus response and to standing, 
and the time spent in lateral and sternal recumbency, with different anaesthetic protocols.  
 
Anaesthetic 
Protocol 
Induction 
time  
(sec) 
Time to 
muscle 
relaxation 
(min) 
Time to 
noxious 
stimulus 
response 
(min) 
Time in 
lateral 
recumbency 
(min) 
Time in 
sternal 
recumbency 
(min) 
Time to 
standing 
(min) 
RK 118±10  3.5±0.5  18±6  27±2  8±2  37±4 
ARK    74±6* 2.8±0.4  22±2  32±2  7±3  39±4 
RDK 103±8  1.9±0.3*    31±2# 38±4  6±2  45±5 
RBK   96±4  3.9±2.5  27±3  32±3  19±5* 51±7 
 
RK=romifidine and ketamine, ARK=acepromazine romifidine and ketamine, 
RDK=romifidine, diazepam and ketamine, RBK=romifidine, butorphanol  and  ketamine.     
* = Significantly different from all other combinations. # = Significantly different from RK 
and ARK. 
 
Prolongation of dissociative anaesthesia 
The minor cardiorespiratory depression produced by dissociative anaesthetics 
makes them suitable for field anaesthesia, but a disadvantage, especially in the 
horse, is the variation in the individual time spent in anaesthesia and the often 
abrupt recovery. The altered reflex pattern after administration of dissociative 
anaesthetics compared to inhalation anaesthesia (Guedel 1937; Campbell & 
Lawson 1958) makes it difficult to evaluate the progress of anaesthetic depth. A 
lack of response to surgery has been suggested as the most reliable sign of 
adequate anaesthetic depth during dissociative anaesthesia (Hall & Clarke 1991). 
In field practice prolongation of anaesthesia is often required, if the horse wakens 
sooner than expected or the surgical procedure is lengthened by complications. If 
the anaesthesia has to be performed without skilled assistants, it could be an 
advantage if further anaesthesia could be given on a time basis.  
 In study II the effects of prolongation of dissociative anaesthesia were 
investigated. A repeated injection of ketamine (RK+K) or of both ketamine and 
romifidine (RK+RK) was given 18 minutes after the horses had assumed lateral 
recumbency. This time was based on results from a previous investigation, in 
which no horse above 350 kg showed signs of light anaesthesia before 18 minutes 
(Marntell et al. 1994). The use of ketamine alone for prolongation was chosen 
because the effect of romifidine has been reported to last longer than that of 
xylazine and detomidine (England et al. 1992). In the third protocol in the 
comparison, anaesthesia was induced with a bolus injection of tiletamine-
zolazepam (RZ) instead of ketamine. Ketamine and tiletamine are both congeners 
to phencyclidine and are referred to as dissociative anaesthetics, and most of the 
pharmacological actions of tiletamine are similar to those of ketamine (Branson 
2001). Tiletamine is commercially available in a combination with zolazepam 
(Zoletil
®). The drug combination is reconstituted in sterile water; this provides 
both tiletamine and zolazepam, in equivalent doses. Doses of this preparation are 
expressed in milligrams of the drug combination, e.g. 1.4 mg/kg Zoletil (0.7   18
mg/kg tiletamine and 0.7 mg/kg zolazepam). Tiletamine-zolazepam and α2-
agonists have been reported to produce a longer duration of anaesthesia in horses 
compared to α2-agonists and ketamine (Matthews et al. 1991a) and are possible 
alternatives during field anaesthesia for longer procedures.  
 The anaesthesia with tiletamine-zolazepam and the prolonged anaesthesia 
produced with both romifidine and ketamine were smooth. When ketamine was 
given alone for prolongation, at 18 minutes of anaesthesia, the horses showed 
more muscle twitching and leg rigidity compared to prolongation with both 
ketamine and romifidine. When the anaesthesia was prolonged with ketamine 
alone, one horse galloped in its sleep and another horse rose to the sternal position, 
but no contact could be established and the head was held down, and after 2 
minutes the horse relaxed in lateral recumbency. The initial injection of romifidine 
did not give sufficient muscle relaxation to abolish the catalepsy following a 
repeated injection of ketamine. It is possible that an injection of ketamine earlier in 
the anaesthesia would have produced less catalepsy. However, on the basis of the 
present results repeated injection of ketamine alone cannot be recommended after 
sedation with romifidine. There was no difference between the three protocols 
(RK+K, RK+RK and RZ) in the average time to response to noxious stimuli. The 
average time spent in lateral recumbency was 38 minutes with protocol RK+K 
(Table 3), significantly shorter than with the other two protocols RZ and RK+RK 
in study II. 
 
Table 3 The average time spent in lateral and sternal recumbency and time from induction 
until standing again, with all anaesthetic protocols used in the studies.  
 
Protocol  Average time 
(range) in lateral 
recumbency 
(min) 
Average time 
(range) in 
sternal 
recumbency 
(min) 
Average time 
(range) from 
induction until 
standing again 
(min) 
RK                 (n=6)  27 (20-36)  8 (0-18)  37 (20-45) 
ARK              (n=6)  32 (23-40)  7 (0-16)  39 (23-51) 
RBK              (n=6)  32 (20-42)  19 (7-40)  51 (32-78) 
RDK              (n=6)  38 (27-57)  6 (0-10)  45 (27-62) 
RK + K          (n=6)  38 (35-46)  5 (0-13)  43 (35-51) 
RK + RK       (n=6)  43 (40-49)  6 (0-16)  49 (40-55) 
RZ                             (n=6)  45 (36-55)  11(0-33)  56 (36-66) 
RBZ                           (n=6)  61 (46-74)  4 (0-10)  65 (53-82) 
ARBZ           (n=6)  65 (40-86)  5 (0-13)  70 (43-86) 
ARBZ-O2                  (n=6)  67 (40-81)  4 (0-12)  71 (51-82) 
RZ-hospital            (n=6)  48 10  58 
ARZ-hospital            (n=11)  52 12  74 
ARBZ-hospital        (n=9)  61 12  73 
ARBZ-field      (n=31)  49 (31-73)  6 (0-23)  55 (32-78) 
 
 Physiological effects of sedation 
Ventilation and gas exchange 
Decreased arterial oxygen tension was observed during sedation in studies I-V. 
Impaired arterial oxygenation has been reported during sedation of horses with 
romifidine alone or in combination with butorphanol (Clarke et al. 1991) and 
during sedation with detomidine alone or in combination with butorphanol (Short 
et al. 1986; Lavoie et al. 1996). The decrease in PaO2 during detomidine sedation 
(III) could mainly be attributed to reduced cardiac output and increased VA/Q 
mismatch, hypoventilation increased after subsequent butorphanol administration 
(Fig. 5). 
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Figure 5 Distribution of ventilation-perfusion ratio (VA/Q) in two horses (444 kg and 380 
kg).  The top panels represent the VA/Q distribution in standing horses (Unsedated). The 
middle panels represent the VA/Q distribution 15 minutes after detomidine sedation 
(Detomidine). The lower panels represent the VA/Q distribution 15 minutes after additional 
sedation with butorphanol (Detomidine & Butorphanol). Note the impaired arterial oxygen 
tension (PaO2) during sedation in both the middle and bottom panels. During sedation with 
detomidine, cardiac output (Qt) decreased and there was an increase in ventilation-
perfusion mismatch (broader base of ventilation-perfusion ratio and increased SD of blood 
flow log distribution (log SDQ) compared to the unsedated horses. The intrapulmonary 
shunt was minimal. During sedation with detomidine and butorphanol, the impaired PaO2 
was a result of increase in ventilation-perfusion mismatch and both Qt and expired minute 
ventilation (VE) were lower than in the unsedated horse. 
  19The decrease in PaO2 during sedation with romifidine and butorphanol was also 
attributed to reduced cardiac output and increased VA/Q mismatch (Fig. 6). 
Hypoventilation, right to left vascular shunt and diffusion limitation of oxygen 
were negligible, as assessed by the multiple inert gas elimination technique. 
Cardiac output was significantly higher during sedation including acepromazine, 
compared to sedation without acepromazine. The sedation protocol ARBZ, 
including acepromazine, maintained log SDQ at baseline value (IV).  A reduction 
in cardiac output can cause a fall in PvO2, which results in a fall in PaO2 for the 
same degree of ventilation-perfusion mismatch (West 1987). Thus, the reduced 
cardiac output in protocol RBZ during sedation may have contributed to the 
reduction in PvO2 and PaO2, especially since a slight but significant increase in 
VA/Q mismatch was observed concurrently. Further, the decrease in cardiac output 
may cause a larger vertical difference in perfusion in upper than in lower lung 
regions. This may increase VA/Q mismatch. 
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Figure 6  Distribution of ventilation-perfusion ratio (VA/Q) in one horse with different 
sedation protocols. In protocol RBZ romifidine and butorphanol were administered and in 
protocol ARBZ acepromazine, romifidine and butorphanol were given. During sedation the 
cardiac output (Qt) and arterial oxygen tension (PaO2) were lower and ventilation-
perfusion mismatch (log SDQ) was higher in protocol RBZ than in ARBZ. The 
intrapulmonary shunt was similar to the baseline value of the unsedated horse in both 
protocols. Note the good matching of ventilation and perfusion and the narrow base of the 
ventilation-perfusion ratio in protocol ARBZ. 
 
Circulation 
The decrease in cardiac output during sedation with romifidine and butorphanol 
(IV-V) and detomidine (III) is in line with earlier reports after sedation with α2-
agonists in horses (Muir et al. 1979; Wagner et al. 1991; Yamashita et al. 2000; 
Freeman et al. 2002). Inclusion of acepromazine in the sedation resulted in better 
maintained cardiac output (IV). In halothane-anaesthetised horses, injection of 
acepromazine increased cardiac output through an increased stroke volume, while 
injection of the α2-agonist xylazine resulted in decreased cardiac output due to a 
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decreased heart rate (Steffey et al. 1985). In study IV there was no difference in 
stroke volume between protocols, indicating that the higher cardiac output in the 
sedation including acepromazine was attributed to a better maintained heart rate. 
Better maintenance of the heart rate during sedation was also found in study I, 
where sedation with acepromazine and romifidine improved the heart rate 
compared to romifidine alone. The reason for this effect may be reversal of reflex 
bradycardia and/or alteration of vagal and/or sympathetic tone. Sedation including 
acepromazine also prevented the significant increase in TSR and mean SAP (IV). 
Sedation with acepromazine and xylazine is reported to abolish the increase in 
arterial pressure caused by xylazine on its own (Muir et al. 1979). Acepromazine 
used alone in horses results in hypotension (Muir et al. 1979; Parry et al. 1982) 
and is reported to increase digital blood flow, an effect proposed to be the result of 
decreased peripheral resistance, due to blockade of α-receptors (Hunt et al. 1994). 
The reason for the abolition of the increases in SAP and TSR in the present study 
may be that vasoconstriction produced by romifidine is counteracted by 
vasodilatation caused by acepromazine, or that acepromazine blocks postsynaptic 
α-receptors, inhibiting the vascular effects of romifidine. The exact 
pharmacological receptor mechanism underlying acepromazine’s ability to 
maintain the circulatory parameters closer to baseline values during sedation with 
α2-agonists remains to be clarified. 
 
Physiological effects of anaesthesia 
Ventilation and gas exchange 
The impaired arterial oxygenation observed in studies I, II, IV, V and VI during 
dissociative anaesthesia is in accordance with earlier findings (Muir et al. 1977, 
1999; Hall & Taylor, 1981; Hubbell et al. 1989; Matthews et al. 1991a; Wan et al. 
1992). Some horses displayed an apneustic breathing pattern (Biot’s breathing), 
where several breaths are taken quickly, followed by a pause. This has been noted 
in several investigations during both ketamine and tiletamine-zolazepam 
anaesthesia in horses (Ellis et al. 1977; Hubbell et al. 1989; Matthews et al. 
1991a). In our investigation the altered breathing pattern in some individuals did 
not affect the respiratory rate, minute ventilation or increased PaCO2 during 
anaesthesia. Additional premedication with butorphanol or diazepam did not, in 
study I, alter the influence of romifidine and ketamine on the cardiorespiratory 
parameters. The decreased PaO2 during dissociative anaesthesia observed in study 
IV could mainly be attributed to a significant increase in shunt and VA/Q 
mismatch. Hypoventilation and diffusion limitation of oxygen were negligible.  
 In  study  II, there were no significant differences in cardiorespiratory parameters 
between the protocols RK+K, RK+RK and RZ. With protocol RZ the lowest mean 
PaO2 (8.0 kPa) was noted 5 minutes after induction of anaesthesia, while the 
lowest mean value with RK anaesthesia (8.7 kPa) was noted when the anaesthesia 
was prolonged with both the α2-agonist and ketamine. Interestingly, the lowest 
PaO2, in both protocol RZ and RK+RK, was observed at the same time as the most 
pronounced increase in mean arterial blood pressure. Inclusion of acepromazine in 
the protocol (study IV) resulted in a higher PaO2 and higher arterial oxygen 
saturation compared to the protocol without acepromazine. The increased ventilation/perfusion mismatch in the protocol without acepromazine contributed 
to greater impairment of arterial oxygenation (Fig. 7). An explanation for the 
increased mismatch could be the significantly elevated PAP with RBZ compared 
to ARBZ (Fig. 8). It has been reported that increased pulmonary vascular pressure 
attenuated hypoxic pulmonary vasoconstriction (HPV) in dogs (Benumof & 
Wahrenbrock 1975). HPV is important for the distribution of blood flow from 
hypoxic regions in the lung to ventilated areas. Since it is suggested that the pony 
has a stronger HPV response than the dog (Elliott et al. 1991), it is possible that a 
pre-existing increased PAP in the horse may disturb HPV, contributing to a further 
decrease in arterial oxygenation in the protocol without acepromazine. 
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Figure 7 Distribution of ventilation-perfusion ratio (VA/Q) in one horse at 25 minutes of 
tiletamine-zolazepam anaesthesia with different premedication. At 25 minutes of 
anaesthesia, intrapulmonary shunt is evident in both protocols to a similar extent, but a 
lower arterial oxygen tension (PaO2) and increased ventilation-perfusion mismatch (log 
SDQ) were noted in protocol RBZ (romifidine, butorphanol and tiletamine-zolazepam). 
Note the increased mismatch of ventilation and perfusion, with the broader base of the 
ventilation-perfusion ratio, in protocol RBZ compared to protocol ARBZ (acepromazine, 
romifidine, butorphanol and tiletamine-zolazepam). 
 
 
Circulation 
In studies I, II, IV and VI the systemic arterial blood pressure increased during 
dissociative anaesthesia compared to baseline, in agreement with earlier reports on 
α2-agonists and dissociative anaesthetics (Muir et al. 1977, 1999; Clarke et al. 
1986; Hubbell et al. 1989; Wan et al. 1992). When acepromazine was included in 
the premedication there were no significant changes from baseline in SAP (I, IV-
VI) or TSR (IV) during dissociative anaesthesia. One concern with the use of 
acepromazine is the development of hypotension. This is related both to the dose 
and route of administration, with high intravenous doses having the most 
pronounced effect (Parry et al. 1982). In the present investigation (I,  IV-VI), 
inclusion of acepromazine given in a low dose intramuscularly in healthy horses 
  22prevented some of the haemodynamic fluctuations, and the mean SAP was well 
maintained above 70 mmHg during anaesthesia. 
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Figure 8 Mean values ± SD (n=6) for mean pulmonary arterial pressure (PAP), cardiac 
output (Qt) and arterial oxygen tension (PaO2) with different protocols. Protocol RBZ 
(romifidine, butorphanol and tiletamine-zolazepam), protocol ARBZ (acepromazine, 
romifidine, butorphanol and tiletamine-zolazepam). Significant differences in PaO2 
between protocols relate to different mechanisms during sedation and anaesthesia. During 
sedation a better maintained Qt preserved PaO2 with the ARBZ protocol. During 
anaesthesia the increased PAP may attenuate hypoxic pulmonary vasoconstriction and 
disturb the matching of perfusion to ventilated areas in the lung, resulting in decreased 
PaO2 with RBZ compared to ARBZ. * = Significant difference between protocols RBZ and 
ARBZ.   
 
 
Breathing air versus >95% oxygen 
Because of the risk of hypoxia and myopathy during field anaesthesia, air 
breathing is not recommended for more than 60 minutes irrespective of the 
injectable drugs chosen (Matthews & Hartsfield 1993). It has been suggested that 
ideally one should be equipped with a tracheal tube, demand valve and oxygen 
cylinder when performing field anaesthesia, in order to be able to ventilate the 
horse for 10-20 minutes or until spontaneous ventilation returns, if apnoea occurs 
(Waterman et al. 1982; Taylor & Clarke 1999). It has also been proposed that 
horses under intravenous anaesthesia could be intubated and connected to a 
demand valve, allowing administration of oxygen and ventilation periodically to 
prevent atelectasis (Riebold et al. 1980).  
The major finding in study V was the development of a significantly larger 
intrapulmonary shunt (13±5%) when the horses inspired oxygen at a high 
concentration compared to air breathing (5±2%) during dissociative anaesthesia. 
This finding is in conformity with reports from human studies that breathing of 
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100% oxygen during preoxygenation and anaesthesia promoted intrapulmonary 
shunt and atelectasis compared to breathing of 30-40% oxygen (Reber et al. 1996; 
Rothen  et al. 1995a, 1996).  In the present investigation inhalation of a high 
fraction of oxygen increased PaO2, as expected, but at the same time created a 
significantly larger intrapulmonary shunt (Fig. 9). During air breathing in the 
present study the mean shunt (8% at 25 minutes) was found to be less pronounced 
than the mean shunt of 20% or more previously observed in anaesthetised horses 
in lateral recumbency in which the anaesthesia was maintained with halothane or 
isoflurane in oxygen (Nyman & Hedenstierna 1989; Moens et al. 1994). Although 
no direct comparison is possible, the difference might be attributable to the use of 
different fractions of inhaled oxygen, drug-induced differences or better preserved 
muscular tone, particularly the diaphragm tone, during dissociative anaesthesia. 
Spontaneously breathing human subjects anaesthetised with ketamine alone are 
reported to have well matched pulmonary ventilation and perfusion without shunt 
(Tokics et al. 1987). In the present study in horses, the dissociative anaesthetic 
was combined with drugs that enhance muscle relaxation (romifidine, zolazepam), 
and intrapulmonary shunt was evident.  
A previous investigation has revealed that in the horse, increased shunt is mainly 
created by collapsed lung tissue (atelectasis) in the dependent part of the horse 
lung (Nyman et al. 1990). In the border area between ventilated and non-
ventilated lung areas, the composition of the inhaled gas will affect the ability of 
the alveoli to stay open. If a lung unit is entirely closed off, the time taken for the 
alveoli to collapse has been estimated to be 6-9 hours if the unit contains air and 
about 8 minutes if it contains 100% oxygen (Joyce et al. 1993). After a 
recruitment manoeuvre in anaesthetised human patients atelectasis recurred within 
5 minutes if the patients were ventilated with FIO2=1.0, in contrast to the group 
ventilated with FIO2=0.4, where atelectasis was eliminated for at least 40 minutes 
(Rothen et al. 1995b) Thus, in the present study the shunt may be the result of 
compression atelectasis due to the relaxed diaphragm tone and the recumbent 
position with both protocols during anaesthesia. The significantly larger shunt 
after breathing of >95% oxygen may be the result of transformation of 
intermittently closed alveoli to atelectasis by resorption of oxygen by the blood. 
 
Return to air after high oxygen breathing 
There are reports in humans showing that atelectasis and impairment of the lung 
function, including decreased PaO2, persist for up to four days or more 
postoperatively, despite standard physiotherapy and mobilisation of the patient 
(Lindberg et al. 1992). In study V, in horses, the intrapulmonary shunt was still 
significantly larger with the O2 protocol ten minutes after return to air breathing 
compared to the AIR protocol (Fig. 9), but no significant difference was found in 
PaO2 between the protocols at that time. This may be explained by the presence of 
low VA/Q and more mismatch between ventilation and perfusion (log SDQ) in the 
AIR protocol (Fig. 9). After 25 minutes of anaesthesia the VA/Q distribution was 
not measured in study V.  
In humans, inhalation of pure oxygen at the end of anaesthesia promotes 
postoperative atelectasis (Benoit et al. 2002). In horses it has been reported that 
the hypoxaemia that developed during anaesthesia with halothane or isoflurane in 100% oxygen persisted into recovery in lateral recumbency despite oxygen 
supplementation (Trim & Wan 1990). Gleed & Dobson (1988) found that PaO2 
was impaired during inhalation anaesthesia in dorsal and lateral recumbency, but 
PaO2 increased rapidly when the horses were turned to sternal recumbency. Thus, 
it seems likely that the intrapulmonary shunt induced during inhalation of high 
oxygen concentrations may persist into recovery in lateral recumbency. However, 
the shunt may be reduced during sternal recumbency and standing. In the healthy 
horses in study V, five minutes after standing PaO2 had returned to the baseline 
level and it seems unlikely that intrapulmonary shunt was present after standing. 
The recovery period is critical for this species and the effect of different oxygen 
concentrations during anaesthesia on the appearance and disappearance of 
intrapulmonary shunt during and after recovery needs to be investigated.  
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Figure 9 Distribution of ventilation-perfusion ratio (VA/Q) in one horse at 15 and 25 
minutes of anaesthesia (ANE 15’ and ANE 25’). At ANE 15’ the intrapulmonary shunt was 
larger when the horse had breathed > 95% oxygen (protocol O2) than when it had breathed 
21% oxygen (protocol AIR). At ANE 25´ the shunt introduced during O2 breathing remained 
larger; this was 10 minutes after the inspired oxygen concentration was reduced to 21%, 
possibly indicating persistence of the resorption atelectasis produced during high O2 
breathing. 
  25Oxygen delivery and oxygen extraction 
There was a significant difference in haemoglobin concentration between protocol 
RBZ and protocol ARBZ during sedation and anaesthesia (Fig. 10). The Hb was 
significantly increased during sedation with the RBZ protocol compared to 
baseline.  The increase may be due to a physiological response to the decreased 
PaO2 or a drug effect. However, the haemoglobin did not continue to increase 
concurrently with the further decrease in PaO2 induced by anaesthesia and 
recumbency. Acepromazine is reported to decrease the haematocrit in horses 
(Ballard et al. 1982; Parry & Andersson 1983). The results obtained by Parry and 
Andersson support the theory that acepromazine causes splenic relaxation and 
consequent erythrocyte storage. Xylazine is reported to produce a contractile 
effect on the canine spleen (Hubbell & Muir 1982). It has been demonstrated that 
intramuscular administration of acepromazine 0.03 or 0.3 mg/kg given 15 minutes 
before  α-agonists (e.g. adrenaline) causes an attenuation or almost complete 
inhibition, respectively, of the α-agonist-induced increase in haematocrit in horses 
(Snow 1979). Thus, the increase in haemoglobin concentration is most likely the 
result of a contractile effect of the α2-agonist romifidine on the spleen. With the 
ARBZ protocol, acepromazine may prevent the contractile effect of romifidine and 
may cause splenic relaxation, with consequent erythrocyte storage. 
 
0
2
4
6
8
10
12
14
Baseline Sedation 15´ 25´
g
/
1
0
0
 
m
l
Time in anaesthesia (min)
Haemoglobin concentration
B*
* *
RBZ
ARBZ
0
2
4
6
8
10
12
14
Baseline Sedation 15´ 25´
g
/
1
0
0
 
m
l
Time in anaesthesia (min)
Haemoglobin concentration
B*
* *
RBZ
ARBZ
RBZ
ARBZ
 
Figure 10 Mean value ± SD (n=6) for haemoglobin concentration with protocol RBZ 
(romifidine, butorphanol and tiletamine-zolazepam) and protocol ARBZ (acepromazine, 
romifidine, butorphanol and tiletamine-zolazepam). * = Significant difference between 
protocol RBZ and protocol ARBZ. B = significant difference compared to baseline. 
 
A higher haemoglobin concentration implies a greater capacity of the blood to 
carry oxygen. Although the contractile effect of the α2-agonist on the spleen 
increases the oxygen-carrying capacity of the blood in RBZ, this effect was 
overridden by the pronounced decrease in Qt and increase in TSR during sedation, 
resulting in increased oxygen extraction during sedation (Fig. 11 a and b). During 
the later part of the anaesthesia the arterial oxygenation was higher with ARBZ 
than with RBZ, although the calculated oxygen delivery was lower with ARBZ. At 
this time the cardiac output values were comparable and the reason for the 
difference in oxygen delivery would mainly be due to the difference in 
  26haemoglobin concentration between protocols. There was no significant difference 
between the two protocols in calculated oxygen uptake or oxygen extraction. A 
slight increase in plasma lactate was observed in two horses after induction of 
anaesthesia (Fig. 12, own unpublished data). However, the plasma lactate 
decreased in these two horses during the short anaesthesia and was comparable to 
baseline levels at the end of anaesthesia. Muscle enzymes (ASAT) and (CK) were 
measured in four horses with protocols ARK, RBK, RDK, RK+K, RK+RK and 
RZ (own unpublished data) and were within the normal range after anaesthesia (4-
6 and 2-5 µkat/l, respectively), indicating that there was no muscle damage 
postoperatively. 
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Figure 11 a and b Mean value ± SD (n=6) for oxygen delivery and arterial-mixed venous 
oxygen content difference with protocols RBZ (romifidine, butorphanol and tiletamine-
zolazepam) and protocol ARBZ (acepromazine, romifidine, butorphanol and tiletamine-
zolazepam). * = Significant difference between protocol RBZ and protocol ARBZ. B = 
significant difference compared to baseline. 
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Figure 12 Plasma lactate value in one horse with protocols RK+K, RBK and RDK, and two 
horses (mean±SD) with protocols RK+RK, ARK, and RZ.  
 
 
Sedation versus anaesthesia 
Although the arterial oxygenation was further reduced by anaesthesia and lateral 
recumbency during air breathing, the oxygen delivery (Fig. 11) was not further 
impaired compared to that during sedation. The oxygen extraction C(a-v)O2 was 
improved during anaesthesia compared to sedation. In study V a significant 
decrease in PvO2 was only observed during sedation (Fig. 13). PaO2 gives only 
minor information about oxygenation of the tissue. Additional information may be 
retrieved from PvO2, as this is influenced by PaO2, blood flow, oxygen extraction 
and consumption and blood pH. Mixed venous oxygen tension has been found to 
be a better predictor of hyperlactataemia and death than either arterial PaO2 or Qt 
alone in critically ill human patients (Kasnitz et al. 1976). In an equine study by 
Freeman et al. (2002), PvO2 was significantly decreased after romifidine sedation 
and the decrease persisted during the 2 hours of observations. The proposed cause 
of the low PvO2 was the cardiovascular effects of the α2-agonist including 
decreased cardiac output, shift in vascular resistance and blood pressure. In the 
present study, administration of the dissociative anaesthetic improved the 
circulation and PvO2. During the entire anaesthesia with air breathing, PvO2 was at 
the same level as the baseline values, indicating that the oxygen delivery to the 
body was sufficient to cover the overall tissue demand in these healthy horses.  
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Figure 13 Mean ± SD (n = 6) values for mixed venous oxygen tension (PvO2) during 
protocol ARBZ (acepromazine, romifidine, butorphanol and tiletamine-zolazepam), 
anaesthesia with air breathing (AIR) or FIO2>95% in the first 15 minutes of anaesthesia 
(O2). During anaesthesia with air breathing PvO2 was at the same level as at baseline, i.e. in 
the standing awake horse, indicating that the oxygen delivered was sufficient to cover the 
tissue demand. However, PvO2 was significantly decreased during sedation compared to the 
baseline value. Inspiration of >95% oxygen (O2) resulted in PvO2 values in excess of those 
in the standing awake horse. B = significant difference from baseline, * = significant 
difference between protocols. 
 
 
Clinical application 
During the clinical investigation (study VI) the horses could not serve as their own 
controls and individual variations may have influenced comparisons between 
protocols. The systemic arterial blood pressure was significantly higher during 
protocol RZ than during the protocols including acepromazine, in accordance with 
findings in study IV. Further, the arterial oxygen tension was lowest in the group 
without acepromazine, although the horses in this group were on average 50 kg 
lighter than those in the other two groups. Hypoxaemia has long been recognised 
as a common and potentially hazardous side effect of anaesthesia in horses, 
although a link between death and hypoxaemia has not been demonstrated (Taylor 
2002). The effect of non-fatal hypoxaemia is difficult to assess and the time factor 
may play an important role. During inhalation anaesthesia in ponies, 20 minutes of 
PaO2 between 4.4 and 5.8 kPa (33-44 mm Hg) did not have any detectable 
deleterious effect on recovery or postoperative well-being (Taylor 1998). In an 
investigation by Whitehair et al. (1996), horses were exposed to three hours of 
hypoxaemia (PaO2 6.7±0.7 [kPa 50±5 mm Hg]) during inhalation anaesthesia with 
isoflurane or halothane. The horses were reported to be lethargic to various 
degrees, with decreased appetite, after halothane anaesthesia. After isoflurane 
anaesthesia the horses appeared to show normal behaviour, but some had a 
decreased appetite.  
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In the present investigation with client-owned horses, a central venous catheter 
was not placed, but instead jugular venous blood was sampled. A comparison 
between PvO2 and PjvO2 during the ARBZ protocol was therefore made in horses 
owned by the department. During anaesthesia with ARBZ there was a good 
correlation between mixed venous and jugular venous oxygen tension. The RZ 
group showed significantly lower oxygen tension in jugular venous blood 
compared to the group given ARBZ, during anaesthesia. This suggests that the 
horses without acepromazine have an overall larger extraction of oxygen when the 
blood passes through the tissue. In study V, anaesthesia with air breathing during 
protocol ARBZ resulted in PvO2 similar to the standing unsedated values, 
indicating that the oxygen delivery was sufficient to cover the overall tissue 
demand. The results of study VI including surgery suggest a similar situation, with 
sufficient oxygen delivery. With all protocols the PjvO2 values were well above 
the values of internal jugular venous oxygen tension, 2.7 kPa (20 mmHg), 
reported to produce unconsciousness whatever the cause (Nunn 1993). 
The analgesia was not sufficient in the RZ protocol and half of the colts in this 
group needed further anaesthesia to complete the surgery. The analgesia was better 
in the other two groups when acepromazine was included in the premedication. 
Acepromazine, which is without analgesic properties of its own, is reported to 
give significantly longer analgesia in dogs when combined with oxymorphone 
compared to oxymorphone alone (Barnhart et al. 2000). A combination of 
butorphanol, an opioid analgesic, and romifidine in horses is reported to reduce 
the reaction to touch and audiovisual stimuli more than romifidine on its own 
(Clarke et al. 1991). Further, standing sedation in horses is reported to be superior 
with a combination of acepromazine, xylazine and methadone compared to 
acepromazine and xylazine (Nilsfors et al. 1988). Acepromazine, but also 
butorphanol, may have contributed to the decreased need of additional anaesthesia 
in the ARBZ group during castration.  
It is concluded from the castrations under hospital conditions that premedication 
with acepromazine and butorphanol in addition to romifidine before anaesthesia 
with tiletamine-zolazepam improves the anaesthesia and analgesia without having 
adverse effects on the cardiorespiratory function or on the quality of induction and 
recovery in healthy horses.  
 
Field conditions 
Since the ARBZ protocol was considered to be the most suitable for castrations 
under hospital conditions, it was chosen for castration of colts in field practice. As 
22% needed further anaesthesia when this protocol was used at the animal 
hospital, it was expected that approximately 7 of the 31 colts would need further 
anaesthesia under field conditions. However, none of the 31 colts castrated in the 
field needed supplementary anaesthesia. One explanation for this result may be 
that the colts operated on in the animal hospital had a higher sympathetic tone 
before sedation and anaesthesia. The colts had previously been transported to the 
animal hospital, some for the first time. In this new environment they were placed 
in boxes within sight and hearing distance of other, unknown colts. These 
environmental changes may have induced a flight response in the horses. Under 
field conditions the colts were kept in their own environment and together with   31
colts of their own known herd, where a herd hierarchy was already established. 
Although many people were involved, the novelty stimuli during field castration 
may have been less pronounced than during the procedure at the animal hospital. 
It was our subjective impression that the sedation of the colts was deeper under 
field conditions, resulting in better anaesthesia and adequate analgesia for surgery. 
With the ARBZ protocol there was no difference in arterial oxygen tension or 
carbon dioxide tension during anaesthesia between colts castrated in the animal 
hospital and those treated under field conditions. There was a difference in heart 
rate between the two groups. Yearlings are reported to have a higher heart rate 
than older horses (Rossdale & Wreford 1989, Visser et al. 2002). On average the 
colts in field practice were 1.5 years old and those in the animal hospital 2.5 years. 
As the difference in heart rate was evident at baseline, before any drug 
administration, the difference during anaesthesia was probably age-related. 
One disadvantage of the use of a bolus dose of a dissociative anaesthetic is the 
individual differences in the duration of anaesthesia and the often abrupt recovery. 
In the case of the dissociative anaesthetic drug ketamine, it seems that recovery in 
the horse is mainly a result of rapid redistribution of the drug from the central 
compartment, which will explain the abrupt recovery often observed in the horse 
(Waterman  et al. 1987). In the present investigation, with protocol ARBZ the 
average time spent in lateral recumbency was approximately ten minutes shorter 
under field conditions than during treatment at the animal hospital. This result 
seemed at first slightly surprising, as the anaesthesia was judged to be deeper 
under field conditions. The higher heart rate under field conditions may have 
generated a better cardiac output and thereby faster redistribution of the 
dissociative anaesthetic, resulting in a shorter period of anaesthesia. The 
anaesthesia and analgesia were sufficient for clamping of the second spermatic 
cord at an average time of 12.5 minutes after induction, which allowed 
inexperienced surgeons enough time to perform the castration procedure under 
field conditions. However, veterinarians planning to use this anaesthetic protocol 
in field practice must take into consideration the individual variation in the time 
spent in lateral recumbency, in this study 30-70 minutes. The time from 
completion of surgery to return of the horse to the standing position was 
unnecessarily long in many cases. Other drug combinations and/or other relative 
proportions of dissociative anaesthetic and benzodiazepine might result in 
anaesthesia sufficient for castration and with a shorter recovery time. Prolongation 
of the anaesthesia was not necessary under field conditions. The recommendation 
to avoid field anaesthesia lasting more than 60 minutes without a possibility of 
giving supplementary oxygen (Matthews & Hartsfield 1993) is still accepted, but 
further research is of interest in this area. As with all dissociative anaesthesia in 
horses, prerequisites for a successful result are deep sedation, undisturbed time 
after induction, proper positioning to avoid muscle ischaemia, and unforced 
recovery. 
In summary, the clinical study showed that under hospital conditions some 
horses, with all three anaesthetic protocols, needed supplementary anaesthesia to 
complete surgery. Tiletamine-zolazepam anaesthesia, after premedication with 
acepromazine, romifidine and butorphanol, provided sufficient anaesthesia for 
castration 5-20 minutes after induction under field conditions. Cardiorespiratory   32
changes were within acceptable limits in these clinically healthy colts with normal 
haemoglobin concentrations. The quality of induction and recovery were good. 
 
 
Summary and suggested future research 
In total, in these studies we have given 117 dissociative anaesthesias in horses, 
without any major complications or mortality. All inductions, anaesthesias and 
recoveries have been calm without excitation. The addition of diazepam or 
zolazepam resulted in earlier muscle relaxation, and with these drugs a tail holder 
may therefore be advisable during the induction. In most cases a standing position 
was achieved at the first attempt and only two horses needed more than one 
attempt. Tiletamine-zolazepam anaesthesia, after premedication with 
acepromazine, romifidine and butorphanol, proved to be suitable for castration of 
colts in a teaching situation under field conditions. However, at the animal hospital 
there was a need for supplementary anaesthesia to complete surgery in some of the 
cases. Cardiorespiratory changes were within acceptable limits during air 
breathing in these clinically healthy colts. 
 
Future research 
The anaesthesia after sedation with acepromazine, romifidine and butorphanol 
followed by tiletamine-zolazepam was reliable but sometimes the time in 
recumbency was unnecessarily long. Further investigations with replacement of 
tiletamine-zolazepam by ketamine and diazepam but with inclusion of 
acepromazine and butorphanol would be of interest. 
One of the major findings during anaesthesia was the development of a 
significantly larger intrapulmonary shunt when the horses breathed high oxygen 
concentrations compared to air breathing. The impact of the proposed resorption 
atelectasis may be more pronounced during longer inhalation anaesthesia. 
Cuvelliez et al. (1990) reported that horses breathing 85% oxygen during 4 hours 
of inhalation anaesthesia displayed increased carbon dioxide retention and a 
progressive increase in the alveolar–arterial oxygen partial pressure difference, 
compared to the situation when the horses breathed 30% oxygen. In humans 
preoxygenation with 100% oxygen increased early formation of atelectasis 
compared to preoxygenation with 80% oxygen or less (Edmark et al. 2003). The 
optimal inspired oxygen concentration during anaesthesia and its effect on the 
critical recovery period is not known in the horse and further studies are needed in 
this area.   
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Conclusions 
 
1.  Additional premedication with butorphanol or diazepam did not alter the 
cardiorespiratory response to romifidine and ketamine, while 
acepromazine maintained the studied circulatory parameters closer to the 
standing unsedated values. Acepromazine and diazepam improved the 
quality of induction and anaesthesia. 
 
2.  No significant differences in cardiorespiratory parameters were found 
between romifidine/tiletamine-zolazepam anaesthesia and prolonged 
anaesthesia with romifidine/ketamine. However, prolongation with 
ketamine alone provided a poor quality of anaesthesia. 
 
3.  The observed decrease in arterial oxygenation during sedation with α2-
agonists was manly attributed to a reduced cardiac output and increased 
VA/Q mismatch. During dissociative anaesthesia cardiac output was 
improved, but arterial oxygenation was further impaired, as a result of 
increased intrapulmonary shunt and mismatch. Addition of acepromazine 
to the sedation with romifidine and butorphanol resulted in better 
maintenance of circulation and arterial oxygenation both during sedation 
and during dissociative anaesthesia. Although the arterial oxygenation 
was further impaired by anaesthesia and recumbency compared to that 
during sedation, the oxygen delivery did not decrease further. The 
arterial-mixed venous oxygen content difference and mixed venous 
oxygen tension remained closer to the standing unsedated values during 
anaesthesia than during sedation. 
 
4.  Breathing more than 95 % oxygen during dissociative anaesthesia 
improved arterial oxygenation compared to air breathing, but 
concomitantly increased intrapulmonary shunt and introduced 
hypoventilation.  The intrapulmonary shunt created during anaesthesia 
with high oxygen concentrations persisted when the horses returned to air 
breathing, possibly indicating that resorption atelectasis produced during 
high oxygen breathing subsequently persisted during anaesthesia and 
recumbency. 
 
5. Tiletamine-zolazepam  anaesthesia, after premedication with 
acepromazine, romifidine and butorphanol, proved to be suitable for 
castration of colts under field conditions. Under hospital conditions there 
was a need for supplementary anaesthesia to complete surgery in some 
cases. Cardiorespiratory changes were within acceptable limits during air 
breathing in these clinically healthy colts. 
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